Joy Artin, Yumn A. Elsabagh, Laila Rashed, & Mohamed A. Hussein. (2023). Proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with diffuse systemic sclerosis: A marker of disease activity and severe disease manifestations with potential therapeutic implementations. Archives of Rheumatology, 38(2), 249–256. https://doi.org/10.46497/ArchRheumatol.2023.9638